Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2026
Overcoming adaptive resistance to KRASG12D blockade in pancreatic cancer through vertical pathway inhibitionQingxiang Lin, Alvin A Morales-Giron, Conrad Sander, et al.
Annals of Surgical Oncology|September 13, 2017
Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort StudyFlorian Posch, Richard Partl, Carmen Döller, et al.
ESMO Open|September 24, 2020
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancerSamantha O Perakis, Sabrina Weber, Qing Zhou, et al.
Scientific Reports|April 5, 2019
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysisFlorian Moik, Jakob M Riedl, Thomas Winder, et al.
Therapeutic Advances in Medical Oncology|March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trialJakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2021
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysisJakob M Riedl, Florian Posch, Lena Horvath, et al.
JACC. Cardiooncology|January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint InhibitorsFlorian Moik, Jakob M Riedl, Dominik Barth, et al.
NPJ Precision Oncology|April 22, 2025
Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapiesMarwa Abdel Hamid, Lorenz M Pammer, Silvia Oberparleiter, et al.
Scientific Reports|July 10, 2020
Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapyMarie-Christin Klöckl, Anne-Katrin Kasparek, Jakob M Riedl, et al.
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Pageof 3